Yunzheng Liu

Yunzheng Liu

Auto-generated profile, based on publicly available information

Yunzheng Liu

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2024 in Science Advances
Verified
Journal Article
Open access
JWJinjun Wu
Jinjun Wu
YXYu Xiao
Yu Xiao
YLYunzheng Liu
Yunzheng Liu
LWLi Wen
Li Wen
CJChuanyang Jin
Chuanyang Jin
JFJingyi Fei
Jingyi Fei
Nuclear speckles are nuclear membraneless organelles in higher eukaryotic cells playing a vital role in gene expression. Using an in situ reverse transcription–based sequencing method, we study nuclear speckle–associated human transcripts. Our data indicate the existence of three gene groups whose transcripts demonstrate different speckle localization properties: stably enriched in nuclear speckles, transiently enriched in speckles at the pre–messenger RNA stage, and not enriched. We find that stably enriched transcripts contain inefficiently excised introns and that disruption of nuclear speckles specifically affects splicing of speckle-enriched transcripts. We further reveal RNA sequence features contributing to transcript speckle localization, indicating a tight interplay between transcript speckle enrichment, genome organization, and splicing efficiency. Collectively, our data highlight a role of nuclear speckles in both co- and posttranscriptional splicing regulation. Last, we show that genes with stably enriched transcripts are over-represented among genes with heat shock–up-regulated intron retention, hinting at a connection between speckle localization and cellular stress response.

17 December 2025 in Cancer Discovery
Verified
Journal Article
Open access
YJYiyi Ji
Yiyi Ji
CJCheng-Wei Ju
Cheng-Wei Ju
LCLei Chen
Lei Chen
KSKai Shen
Kai Shen
RSRuopeng Su
Ruopeng Su
WXWei Xue
Wei Xue
Neuroendocrine prostate cancer (NEPC) is an aggressive, therapy-resistant subtype of prostate cancer characterized by lineage plasticity. Although metabolic and signaling molecules are increasingly recognized as modulators of tumor progression, their role in cell fate transition remains unclear. NE (neuroendocrine) tumors produce and accumulate serotonin, a neurotransmitter that regulates diverse physiologic processes. In this study, we identify a tumor-intrinsic serotonin axis as a key driver of NEPC lineage commitment and progression. NEPC endogenously synthesizes serotonin via aromatic L-amino acid decarboxylase (AADC; encoded by DDC) and reuptakes it through the transporter SLC6A4. Mechanistically, high levels of intracellular serotonin promote histone serotonylation at H3K4me3Q5, reconfiguring the H3K4me3 chromatin landscape and downstream gene expression, which drives NE differentiation and is associated with suppressed androgen receptor signaling. Pharmacologic inhibition of serotonin synthesis using the FDA-approved DDC inhibitor carbidopa significantly impairs tumor growth and prolongs survival in both genetically engineered and patient-derived xenograft models, highlighting histone serotonylation as a druggable vulnerability in NEPC. Significance: Collectively, our findings uncover an epigenetically embedded, serotonin-driven lineage program in NEPC, coupling tumor-intrinsic serotonin metabolism with tumor cell fate control, and identify histone serotonylation as a tractable therapeutic vulnerability in lineage-plastic prostate cancer.

12 October 2026 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
HCHongxia Cai
Hongxia Cai
CJCheng-Wei Ju
Cheng-Wei Ju
JCJianfei Chao
Jianfei Chao
YLYunzheng Liu
Yunzheng Liu
PYPeng Ye
Peng Ye
YSYanhong Shi
Yanhong Shi
Reprogramming human somatic cells into induced pluripotent stem cells (iPS cells) provides huge potential for regenerative medicine but its molecular regulation remains incompletely understood. In this study, we identify PUS7 as an RNA modification checkpoint that promotes acquisition of pluripotency. PUS7 loss markedly impairs reprogramming, whereas its overexpression accelerates reprogramming efficiency and kinetics. Mechanistically, PUS7 pseudouridylates U250 of the chromatin-associated noncoding RNA 7SK, enhancing its interaction with the BRG/BRM-associated factor (BAF) complex. Loss of this modification disrupts 7SK–BAF association, reduces BAF chromatin occupancy and decreases global chromatin accessibility. We further establish PSKM (PUS7, SOX2, KLF4, MYC) reprogramming, which generates iPS cells with faithful imprinting, robust lineage potential and improved developmental fidelity. PSKM-iPS cells differentiate efficiently toward neural and hematopoietic lineages and undergo gastrulation-like morphogenesis. These findings link 7SK pseudouridylation to chromatin remodeling and establish PSKM as a framework for generating high-quality human iPS cells for modeling and regenerative medicine.

1 April 2026
Verified
Other
Open access
YJYiyi Ji
Yiyi Ji
CJCheng-Wei Ju
Cheng-Wei Ju
LCLei Chen
Lei Chen
KSKai Shen
Kai Shen
RSRuopeng Su
Ruopeng Su
WXWei Xue
Wei Xue
Neuroendocrine prostate cancer (NEPC) is an aggressive, therapy-resistant subtype of prostate cancer characterized by lineage plasticity. Although metabolic and signaling molecules are increasingly recognized as modulators of tumor progression, their role in cell fate transition remains unclear. NE (neuroendocrine) tumors produce and accumulate serotonin, a neurotransmitter that regulates diverse physiologic processes. In this study, we identify a tumor-intrinsic serotonin axis as a key driver of NEPC lineage commitment and progression. NEPC endogenously synthesizes serotonin via aromatic L-amino acid decarboxylase (AADC; encoded by DDC) and reuptakes it through the transporter SLC6A4. Mechanistically, high levels of intracellular serotonin promote histone serotonylation at H3K4me3Q5, reconfiguring the H3K4me3 chromatin landscape and downstream gene expression, which drives NE differentiation and is associated with suppressed androgen receptor signaling. Pharmacologic inhibition of serotonin synthesis using the FDA-approved DDC inhibitor carbidopa significantly impairs tumor growth and prolongs survival in both genetically engineered and patient-derived xenograft models, highlighting histone serotonylation as a druggable vulnerability in NEPC.Significance:Collectively, our findings uncover an epigenetically embedded, serotonin-driven lineage program in NEPC, coupling tumor-intrinsic serotonin metabolism with tumor cell fate control, and identify histone serotonylation as a tractable therapeutic vulnerability in lineage-plastic prostate cancer.

11 March 2026 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
KHKai Hao
Kai Hao
YLYunzheng Liu
Yunzheng Liu
MBMykel Barrett
Mykel Barrett
ZSZainalabedin Samadi
Zainalabedin Samadi
AZAmirhossein Zarezadeh
Amirhossein Zarezadeh
AAAmjad Askary
Amjad Askary

7 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YLYunzheng Liu
Yunzheng Liu
JPJihye Park
Jihye Park
LALaura Amaya
Laura Amaya
SJSergi Junyent
Sergi Junyent
XSXiangkai Sun
Xiangkai Sun
MZMagdalena Zernicka-Goetz
Magdalena Zernicka-Goetz
How a flexible mammalian embryo gives rise to a reproducible body plan remains unclear, partly because cell lineages cannot be followed continuously in vivo. We combined DNA Typewriter lineage recording with tetraploid complementation to reconstruct high-resolution single-cell genealogies across mouse development and built FateVec, an analysis framework that infers fate-bias dynamics and lineage-associated transcriptional programs from reconstructed phylogenies. Loss of developmental potential proved progressive and asynchronous, with multiple lineages acquiring detectable fate bias before morphological diversification at gastrulation. Within the neural crest, most cells remained multipotent over an extended window, while independent founder clades differed markedly in restriction timing. Extending lineage recording to a stem-cell-derived embryo model revealed that cells with shared transcriptional identities can arise from distinct lineage relationships. We further found embryonic-lineage contributions to extraembryonic-like states, exposing an unexplored lineage plasticity. This lineage-resolved view of embryogenesis reveals that cell identity alone predicts neither developmental ancestry nor the timing of fate restriction.